News 2016-08-25
Porton Hosts An Investor Reception, August 25, 2016.
Changshou [Chongqing Metropolitan Region], China, August 25, 2016: Porton proudly hosted a delegation of >50 investment analysts and corporate finance media professionals from the Shenzhen Stock Exchange at its USFDA-inspected production facility in Changshou, The guests were hosted by Porton Vice-Presidents Mr. Richard Tao, Dr. Tim Yu and Mr. Victor Cao and toured the site, which produces and supplies custom drug intermediates and APIs for many of the world’s most well-known and respected pharmaceutical and biotechnology companies.
Others
More
News 2026-10-22
Simplifying Synthesis with Radical Cross-Coupling: Prof. Phil S. Baran of Scripps Research Lectures at Porton
The event was hosted by Dr. Yongli Zhong, CSO, and attended by Mr. Oliver Ju, Chairman and CEO; Mr. Yunxing Yin, VP and Head of the Small Molecule Platform, and more than 200 R&D and technical staff.
News 2026-10-16
Porton Achieves Third-Party Verification for Its First Commercial Product LCA and PCF Study
Conducted in accordance with ISO 14040:2006 and ISO 14044:2006 (Life Cycle Assessment) and ISO 14067:2018 (Product Carbon Footprint) standards, the study employs a cradle-to-gate system boundary, marking the formal extension of Porton's ESG management from the organizational level to the product level.
